English
Chinese (Simplified)
French
Portuguese
Spanish
German
Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory
Forward
Print
Comment
Molecular Imaging Homepage
Dennis Durmis MITA names chair of board of directors
Researchers find new PET tracer that better detects melanoma than 18F-FDG 18F-P3BZA could become the new gold standard
RadioMedix scores $2 million contract for Targeted Alpha-emitter therapy Treatment for neuroendocrine tumors
FDA clears United Imaging's total-body PET scanner Creating 3D images of entire human body in 15-30 seconds
FDA clears MIM SurePlan molecular radiotherapy software Can measure the absorbed dose from MRT for individual patients
Rob Beanlands ASNC names president for 2019
Former South African nuclear executives to appeal suspensions in court Involves monthslong shutdown of NTP Radioisotopes medical isotope plant
FDA grants Fast Track designation to 64-Cu-Dotatate Used in PET diagnostic exams for suspected neuroendocrine tumors
Editorial takes aim at NRC efforts to lower the bar for nuclear medicine providers 'The NRC has abdicated its role as a protection agency for patients' say authors
Progenics Pharmaceuticals selects Curium as European distributor of PyL Imaging agent for visualizing prostate cancer
New technologies to help expand PET/CT imaging in emerging markets
PET/CT is an important modality today in oncology, and there has been a robust growth in the installation of cyclotrons and PET/CT scanners in developed countries, where the strategy has been to establish centralized radiopharmacies to supply 18FDG to facilities within a distribution grid.
Establishing a conventional cyclotron can be complex due to the significant infrastructure and equipment costs, and the demand for specialized support.
Has exclusive distribution agreement with DDD to sell new Camera systems
UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510
In emerging markets, this centralized distribution model is much more difficult due to economic challenges and transportation logistics. A trend towards smaller and simpler solutions has progressed, with companies offering “table top” cyclotrons with compact and automated radiochemistry units This decentralized strategy enables the users to produce on-demand doses 18FDG and other tracers using an automated and user-friendly technology, providing availability at an affordable cost to these developing countries.
One example is the BG-75 “Dose on Demand” Biomarker Generator from ABT Molecular Imaging. The company offers a 7.5Mev cyclotron with simplified single or small batch 18FDG production, and automated quality control. The solution has made it economically feasible to implement in-house radiopharmaceutical production. For example, Fundacion Valle de Lili Hospital in Cali, Columbia, was having FDG transported via airlines from a city >400 km away at considerable cost. By implementing the first Biomarker Generator System in Colombia, they were able to reduce their 18FDG costs, and expand their scheduling.
Another example can be found in the largest island in Southeast Asia. With a population of 18 million citizens, Borneo had no access to PET/CT due to lack of access to 18FDG. Borneo Medical Center used an existing 35 m2 space in their hospital to install the Biomarker Generator System, and is now the first provider to offer PET/CT.
While having economical, on-demand access to 18FDG is most important for emerging markets to initiate PET/CT, the capability to produce other more specific tracers is equally important. German Oncology Center, who also installed the first Biomarker Generator and PET/CT on the island of Cyprus, is a highly specialized, private oncology center. They not only produce 18FDG, but also other important tracers such as PSMA for prostate imaging, and FET for brain tumor imaging.
The global growth of PET/CT may well be accelerated by this decentralized approach, where hospitals and health care providers can produce on-demand doses of PET radiopharmaceuticals by installing this type of compact, automated, and user-friendly system.
About the author: Rick Rippin is the sales director for ABT Molecular Imaging
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
